The Europe Precision Diagnostics Market is projected to witness market growth of 17.6% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Precision Diagnostics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $3.50 billion by 2031. The UK market is exhibiting a CAGR of 16.6% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 18.9% during (2024 - 2031).
Precision diagnostics encompass a wide range of applications across various fields of medicine, leveraging advanced technologies to enhance diagnostic accuracy, personalize treatment strategies, and improve patient outcomes.
Moreover, precision diagnostics play a crucial role in oncology, where personalized treatment approaches are increasingly based on tumors' genetic and molecular characteristics. Identifying mutations (e.g., BRCA1/2 in breast cancer) influencing cancer risk and treatment response.
Europe faces a high burden of respiratory diseases such as chronic obstructive pulmonary disease and respiratory infections due to factors like air pollution, an aging population, and lifestyle habits. As per Eurostat, in 2020, there were 3,47,867 deaths in the EU resulting from diseases of the respiratory system, equivalent to 6.7 % of all deaths among residents. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively.
The Germany market dominated the Europe Precision Diagnostics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $3.50 billion by 2031. The UK market is exhibiting a CAGR of 16.6% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 18.9% during (2024 - 2031).
Precision diagnostics encompass a wide range of applications across various fields of medicine, leveraging advanced technologies to enhance diagnostic accuracy, personalize treatment strategies, and improve patient outcomes.
Moreover, precision diagnostics play a crucial role in oncology, where personalized treatment approaches are increasingly based on tumors' genetic and molecular characteristics. Identifying mutations (e.g., BRCA1/2 in breast cancer) influencing cancer risk and treatment response.
Europe faces a high burden of respiratory diseases such as chronic obstructive pulmonary disease and respiratory infections due to factors like air pollution, an aging population, and lifestyle habits. As per Eurostat, in 2020, there were 3,47,867 deaths in the EU resulting from diseases of the respiratory system, equivalent to 6.7 % of all deaths among residents. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively.
List of Key Companies Profiled
- Abbott Laboratories
- F.Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- BioMerieux S.A.
- Becton, Dickinson and Company
- Qiagen N.V
- Hologic, Inc.
Market Report Segmentation
By End-use- Clinical Laboratories
- Hospitals
- Others
- Genetic Tests
- Esoteric Tests
- Direct to Consumer Tests
- Others
- Oncology
- Respiratory Diseases
- CNS Disorders
- Immunology
- Skin Diseases
- Genetic Diseases
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Europe Precision Diagnostics Market by End-use
Chapter 6. Europe Precision Diagnostics Market by Type
Chapter 7. Europe Precision Diagnostics Market by Application
Chapter 8. Europe Precision Diagnostics Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- BioMerieux S.A.
- Becton, Dickinson and Company
- Qiagen N.V
- Hologic, Inc.
